TAA/ecdCD40L adenoviral prime-protein boost vaccine for cancer and infectious diseases.
about
Enhancement of protective efficacy through adenoviral vectored vaccine priming and protein boosting strategy encoding triosephosphate isomerase (SjTPI) against Schistosoma japonicum in mice.Adenovirus: the first effective in vivo gene delivery vectorAdenovirus-Mediated Gene Delivery: Potential Applications for Gene and Cell-Based Therapies in the New Era of Personalized Medicine.
P2860
TAA/ecdCD40L adenoviral prime-protein boost vaccine for cancer and infectious diseases.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
TAA/ecdCD40L adenoviral prime-protein boost vaccine for cancer and infectious diseases.
@en
type
label
TAA/ecdCD40L adenoviral prime-protein boost vaccine for cancer and infectious diseases.
@en
prefLabel
TAA/ecdCD40L adenoviral prime-protein boost vaccine for cancer and infectious diseases.
@en
P2093
P2860
P356
P1433
P1476
TAA/ecdCD40L adenoviral prime-protein boost vaccine for cancer and infectious diseases.
@en
P2093
P2860
P2888
P356
10.1038/CGT.2012.87
P577
2012-12-14T00:00:00Z